Applied Genetic Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Applied Genetic prevailing Real Value cannot be determined due to lack of data. The current price of Applied Genetic is $0.0. Our model approximates the value of Applied Genetic from analyzing the firm fundamentals such as Operating Margin of (206.44) %, shares outstanding of 67.63 M, and Return On Equity of -1.61 as well as examining its technical indicators and probability of bankruptcy.

Applied Genetic Total Value Analysis

Applied Genetic is presently anticipated to have valuation of 12.53 M with market capitalization of 26.62 M, debt of 9.12 M, and cash on hands of 46.37 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Applied Genetic fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
12.53 M
26.62 M
9.12 M
46.37 M

Applied Genetic Investor Information

About 30.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.51. Some equities with similar Price to Book (P/B) outperform the market in the long run. Applied Genetic recorded a loss per share of 1.46. The entity had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Applied Genetic's historical financial statements, Applied Genetic is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.

Applied Genetic Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Applied Genetic has an asset utilization ratio of 0.49 percent. This indicates that the Company is making $0.004874 for each dollar of assets. An increasing asset utilization means that Applied Genetic is more efficient with each dollar of assets it utilizes for everyday operations.

Applied Genetic Ownership Allocation

Applied Genetic holds a total of 67.63 Million outstanding shares. Almost 69.23 percent of Applied Genetic outstanding shares are held by general public with 0.85 (percent) owned by insiders and only 29.92 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Applied Genetic Profitability Analysis

The company reported the previous year's revenue of 325 K. Net Loss for the year was (68.94 M) with loss before overhead, payroll, taxes, and interest of (21.44 M).
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Applied Genetic's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Applied Genetic and how it compares across the competition.

Applied Genetic Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding45 M
Retained Earnings-308.2 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in Applied Stock

If you are still planning to invest in Applied Genetic check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Genetic's history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges